길리어드 사이언스, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionSuntrust Banks Inc
Latest Disclosed Ownership271,869 shares
Latest Disclosed Value $ 17,231,000
Suntrust Banks Inc reports 245.51% increase in ownership of GILD / Gilead Sciences, Inc.

On November 12, 2019 - Suntrust Banks Inc filed a 13F-HR form disclosing ownership of 271,869 shares of Gilead Sciences, Inc. (US:GILD) valued at $17,231,057 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 6, 2019 disclosing 78,687 shares of Gilead Sciences, Inc.. This represents a change in shares of 245.51% during the quarter. The current value of the position is $35,114,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 271,869 193,182 245.51 17,231 224.13 0.0900
2019-08-06 2019-06-30 13F GILEAD SCIENCES COM 375558103 78,687 -1,556 -1.94 5,316 1.90 0.0277
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 80,243 -1,934 -2.35 5,217 1.50 0.0275
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 82,177 -5,863 -6.66 5,140 -24.38 0.0296
2019-09-04 2018-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 88,040 -4,434 -4.79 6,797 3.76 0.0351
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 87,062 -5,412 6,721
2019-09-04 2018-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 92,474 -771 -0.83 6,551 -6.81 0.0359
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 94,639 -50,389 6,703
2019-09-04 2018-03-31 13F/A-2 GILEAD SCIENCES COM 375558103 93,245 4,273 4.80 7,030 10.29 0.0393
2018-05-25 2018-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 145,028 51,783 10,932 0.0575
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 124,632 -17,847 9,395
2019-09-03 2017-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 88,972 -131,297 -59.61 6,374 -64.28 0.0370
2018-02-09 2017-12-31 13F GILEAD SCIENCES COM 375558103 142,479 -122,916 10,205
2019-09-03 2017-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 220,269 5,257 2.44 17,846 17.25 0.1060
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 265,395 50,383 21,501
2019-09-04 2017-06-30 13F/A-2 GILEAD SCIENCES COM 375558103 215,012 -22,127 -9.33 15,220 -5.51 0.0931
2019-09-03 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 215,012 0 15,220 0.0931
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 243,070 -21,896 17,202
2019-09-03 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 237,139 -30,429 -11.37 16,107 -15.93 0.1027
2017-05-03 2017-03-31 13F GILEAD SCIENCES COM 375558103 264,966 -2,602 17,994
2017-02-09 2016-12-31 13F GILEAD SCIENCES COM 375558103 267,568 -6,869 -2.50 19,158 -11.75 0.1152
2016-11-09 2016-09-30 13F GILEAD SCIENCES COM 375558103 274,437 -18,051 -6.17 21,710 -11.01 0.1356
2016-08-02 2016-06-30 13F GILEAD SCIENCES COM 375558103 292,488 -4,947 -1.66 24,397 -10.70 0.1493
2016-05-09 2016-03-31 13F GILEAD SCIENCES COM 375558103 297,435 -121,148 -28.94 27,321 -35.49 0.1693
2016-02-10 2015-12-31 13F GILEAD SCIENCES COM 375558103 418,583 19,725 4.95 42,354 8.15 0.2612
2015-11-16 2015-09-30 13F GILEAD SCIENCES COM 375558103 398,858 -13,573 -3.29 39,162 -18.89 0.2645
2015-08-10 2015-06-30 13F GILEAD SCIENCES COM 375558103 412,431 -15,511 -3.62 48,284 14.98 0.3108
2015-05-12 2015-03-31 13F GILEAD SCIENCES COM 375558103 427,942 11,154 2.68 41,992 6.89 0.2697
2015-02-12 2014-12-31 13F GILEAD SCIENCES COM 375558103 416,788 -25,554 -5.78 39,285 -16.57 0.2661
2014-11-14 2014-09-30 13F GILEAD SCIENCES COM 375558103 442,342 94,846 27.29 47,086 63.45 0.3307
2014-08-14 2014-06-30 13F GILEAD SCIENCES COM 375558103 347,496 -619,808 -64.08 28,808 -57.97 0.1999
2014-05-14 2014-03-31 13F GILEAD SCIENCES COM 375558103 967,304 -219,853 -18.52 68,541 -23.12 0.2520
2014-02-12 2013-12-31 13F GILEAD SCIENCES COM 375558103 1,187,157 -6,396 -0.54 89,152 18.81 0.3471
2013-11-04 2013-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 1,193,553 -32,462 -2.65 75,035 19.38 0.2922
2013-10-31 2013-09-30 13F GILEAD SCIENCES COM 375558103 1,193,553 75,035
2013-09-06 2013-06-30 13F/A-1 GILEAD SCIENCES INC COM COM 375558103 1,226,015 1,226,015 62,855 0.2771
2013-08-15 2013-06-30 13F GILEAD SCIENCES INC COM COM 375558103 1,080,900 55,415
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.